中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
姓名: 彭劼
职称: 主任医师 教授
单位: 南方医科大学南方医院 感染内科
简历介绍:

1984.9-1989.7 第一军医大学,学士

1992.9-1995.7 第一军医大学,硕士

1999.9-2002.7 第一军医大学,博士

1989.8-2004.8 第一军医大学南方医院感染内科, 医师,助教;主治,讲师

2004.09-至今 南方医科大学南方医院感染内科 副主任医师,副教授,主任医师,教授,副主任

1, Off-treatment HBV DNA Levels and the Prediction of Relapse After Nucleos(t)ide Analogue Discontinuation in Chronic Hepatitis B: a Prospective Stop Study.  2017,J Infect Dis

2, Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment Cessation. 2017, Clinical Infectious Diseases

3, Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs. 2018, Infection and Drug Resistance

4, Serum Level of Antibodies Against Hepatitis B Core Protein Is Associated With Clinical Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy. 2019, Clinical Gastroenterology and Hepatology

5, Hepatitis B surface antigen kinetics after discontinuation of and retreatment with oral antivirals in non-cirrhotic HBeAg-positive chronic hepatitis B. 2021,  Journal Of Viral Hepatitis

6, Serum hepatitis B virus RNA level is associated with biochemical relapse in chronic hepatitis B patients who discontinued nucleos(t)ide analogue treatment. 2021, Alimentary Pharmacology & Therapeutics

81572000 2016 国家自然科学基金 IL21-CD8+T细胞途径与核苷类药物治疗慢性乙型肝炎停药转归的关系和机制研究

81971949 2020 国家自然科学基金 CXCL13/CXCR5轴与核苷类药物治疗慢性乙肝停药后持久应答的关系和机制研究

 


对于给您带来的不便,我们深表歉意:我们正在采取措施防止机器人程序和页面爬虫程序提交欺诈性表单。请输入正确的验证码来证明你是人类。